GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Housing remained the focus of the NDP on Tuesday, as leader Claudia Chender promised to create a compliance and enforcement ...
The Gazette on MSN1d
Three years and waiting for Canada's made-in-Montreal COVID shotVaccine production is nearly three years behind schedule at a federally owned plant in Montreal and the future of a deal ...
Hosted on MSN16h
'Didn't See Needle Entering His Arm': Netizens Question Canada PM Justin Trudeau’s Edited Flu Shot VideoPosting the video in which Trudeau was seen getting vaccine administrated, he wrote, "It’s that time of year. Take a couple ...
Nova Scotia’s top party leaders are talking traffic congestion, seniors’ health and rental disputes as the provincial ...
A new variant of COVID called XEC — a combination of two Omicron subvariants — is spreading in the middle of flu season.
More Torontonians will be able to get their doses of a new COVID-19 vaccine on Monday. Everyone who is at least six months ...
8d
Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...
The Canadian Press on MSN15h
Nova Scotia Tories promise universal shingles vaccine program for 65 and overNova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles vaccine ...
Two more cases of measles have been confirmed in New Brunswick, bringing the total number of cases to five. On Oct. 24, New ...
Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront ...
Canada approves GSK's RSV vaccine for adults aged 50 to 59 GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback